文献速递泌尿生殖腹部MRUS

级联深度学习算法在双参数MRI前列腺病灶检测中的评估

Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
PubMed 文献 · Radiology · 2024-01-01

这项前瞻性注册研究的二次分析纳入658例男性(1029个MRI可见病灶),评估级联深度学习算法在双参数MRI上检测和分割前列腺病灶的表现,并与放射科医师判读及活检病理对照。算法检出96%的临床显著前列腺癌患者,医师检出98%(P=.23),病灶水平敏感度55%、阳性预测值57%,分割Dice相似系数0.29。

要点

  • 算法对临床显著前列腺癌(ISUP分级分组≥2)的患者水平检出率为96%,与放射科医师的98%无显著差异(P=.23)。
  • 算法检出ISUP分级分组1、2、3、4、5病灶的患者比例分别为84%、96%、96%、95%、98%。
  • 以放射科医师判读为参考,病灶水平检测敏感度55%、阳性预测值57%,平均每人假阳性病灶0.61个。

核心结论

  • AI算法在双参数MRI上检出可疑前列腺癌病灶的表现与经验丰富的放射科医师相当,并能可靠预测病理证实的临床显著病灶。

研究设计与样本

  • 研究为前瞻性注册研究的二次分析,纳入2019年4月至2022年9月间因疑似或已知前列腺癌接受mpMRI及超声引导系统穿刺或系统联合MRI/US融合引导穿刺的连续患者。
  • 共纳入658例男性参与者(中位年龄67岁,IQR 61-71岁),含1029个MRI可见病灶;所有病灶前瞻性按PI-RADS v2.1评估。
  • 评估对象为既往开发的级联深度学习算法,以组织病理学结果和放射科医师判读为参考,采用敏感度、阳性预测值和Dice相似系数比较病灶水平与参与者水平的表现。

诊断标准与关键数值

  • 参与者水平:算法检出96%(282/294;95%CI:94%,98%)的临床显著前列腺癌(ISUP分级分组≥2)患者,放射科医师检出98%(287/294;95%CI:96%,99%),P=.23。
  • 算法检出ISUP分级分组1、2、3、4、5病灶的参与者比例分别为84%(103/122)、96%(152/159)、96%(47/49)、95%(38/40)、98%(45/46)。
  • 以放射科医师判读为参考的病灶水平分析:检测敏感度55%(569/1029;95%CI:52%,58%),阳性预测值57%(535/934;95%CI:54%,61%)。
  • 平均每例参与者假阳性病灶数为0.61个(范围0-3);病灶分割Dice相似系数为0.29。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Multiparametric MRI (mpMRI) improves prostate cancer (PCa) detection compared with systematic biopsy, but its interpretation is prone to interreader variation, which results in performance inconsistency. Artificial intelligence (AI) models can assist in mpMRI interpretation, but large training data sets and extensive model testing are required. Purpose To evaluate a biparametric MRI AI algorithm for intraprostatic lesion detection and segmentation and to compare its performance with radiologist readings and biopsy results. Materials and Methods This secondary analysis of a prospective registry included consecutive patients with suspected or known PCa who underwent mpMRI, US-guided systematic biopsy, or combined systematic and MRI/US fusion-guided biopsy between April 2019 and September 2022. All lesions were prospectively evaluated using Prostate Imaging Reporting and Data System version 2.1. The lesion- and participant-level performance of a previously developed cascaded deep learning algorithm was compared with histopathologic outcomes and radiologist readings using sensitivity, positive predictive value (PPV), and Dice similarity coefficient (DSC). Results A total of 658 male participants (median age, 67 years [IQR, 61-71 years]) with 1029 MRI-visible lesions were included. At histopathologic analysis, 45% (294 of 658) of participants had lesions of International Society of Urological Pathology (ISUP) grade group (GG) 2 or higher. The algorithm identified 96% (282 of 294; 95% CI: 94%, 98%) of all participants with clinically significant PCa, whereas the radiologist identified 98% (287 of 294; 95% CI: 96%, 99%; P = .23). The algorithm identified 84% (103 of 122), 96% (152 of 159), 96% (47 of 49), 95% (38 of 40), and 98% (45 of 46) of participants with ISUP GG 1, 2, 3, 4, and 5 lesions, respectively. In the lesion-level analysis using radiologist ground truth, the detection sensitivity was 55% (569 of 1029; 95% CI: 52%, 58%), and the PPV was 57% (535 of 934; 95% CI: 54%, 61%). The mean number of false-positive lesions per participant was 0.61 (range, 0-3). The lesion segmentation DSC was 0.29. Conclusion The AI algorithm detected cancer-suspicious lesions on biparametric MRI scans with a performance comparable to that of an experienced radiologist. Moreover, the algorithm reliably predicted clinically significant lesions at histopathologic examination. ClinicalTrials.gov Identifier: NCT03354416 © RSNA, 2024 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lin Y, Yilmaz EC, Belue MJ, et al. Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI. Radiology. 2024. PMID: 38713024. doi:10.1148/radiol.230750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。